Status:

ACTIVE_NOT_RECRUITING

Left Bundle Branch Area Pacing Using Conventional Stylet-driven Pacemaker Leads for Cardiac Resynchronization Therapy

Lead Sponsor:

AZ Sint-Jan AV

Conditions:

Heart Failure with Reduced Ejection Fraction

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The aim of this study proposal is to compare the effectiveness of two distinct pacing modalities for cardiac resynchronization therapy. Our primary hypothesis is that left bundle branch area pacing (L...

Detailed Description

Recently some retrospective or uncontrolled studies were published that compared cardiac resynchronization therapy (CRT) using left bundle branch area pacing (LBBAP) and biventricular pacing (BiV), al...

Eligibility Criteria

Inclusion

  • Aged 18 or above
  • Left Ventricular Ejection Fraction (LVEF) and NYHA meeting one off the previous indications documented with transthoracic echocardiography (TTE) no later than 3 months before randomization.
  • New York Heart Association (NYHA) class II-IV
  • Baseline left bundle branch block and QRS \>130ms or QRS \>150ms of any morphology or a wide paced QRS duration.

Exclusion

  • Younger than 18 years old
  • Pregnancy
  • Any unstable medical condition, life expectancy \< 12 months
  • Inability to provide consent or to undergo follow-up
  • Narrow QRS duration (≤130ms) or prolonged QRS duration with typical Right Bundle Branch Block (RBBB) morphology on 12 lead ECG and sinus rhythm.
  • Significant hypertrophic cardiomyopathy - any septum abnormality contra-indicating LBBAP implantation (according to physician's evaluation)
  • Patients who are unable to perform a 6 minute walk test (6MWT) Note: patients should be able to perform a 6 minute walk test, but it is not a requirement to have the test performed before the procedure (e.g. due to inability of planning).

Key Trial Info

Start Date :

September 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2028

Estimated Enrollment :

170 Patients enrolled

Trial Details

Trial ID

NCT05365568

Start Date

September 1 2022

End Date

September 30 2028

Last Update

September 23 2024

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

UZA

Edegem, Antwerpen, Belgium, 2650

2

CHU Charleroi

Lodelinsart, Henegouwen, Belgium, 6042

3

Jessa Ziekenhuis Hasselt

Hasselt, Limburg, Belgium, 3500

4

CHR Citadelle Liège

Liège, Liège, Belgium, 4000